[Centrofacial granulomatous inflammation].
Maetzke
J
J
Klinik für Dermatologie und Allergologie, Universitätsklinikum Ulm, Maienweg 12, 89081 Ulm. julia.maetzke@uniklinik-ulm.de
Hinrichs
R
R
Sigge
A
A
Scharffetter-Kochanek
K
K
D000368:Aged; D000369:Aged, 80 and over; D000904:Antibiotics, Antitubercular / Q000008:administration & dosage / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000627:therapeutic use; D008177:Lupus Vulgaris / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D008297:Male; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D011718:Pyrazinamide / Q000008:administration & dosage / Q000627:therapeutic use; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use; D012867:Skin / Q000382:microbiology / Q000473:pathology; D013997:Time Factors; D016896:Treatment Outcome; D014374:Tuberculin Test
D000904:Antibiotics, Antitubercular; D000995:Antitubercular Agents; D011718:Pyrazinamide; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin